William J. Peters - Jan 7, 2022 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Signature
/s/ William J. Peters
Stock symbol
AMPH
Transactions as of
Jan 7, 2022
Transactions value $
-$494,648
Form type
4
Date filed
1/11/2022, 05:22 PM
Previous filing
Jan 4, 2022
Next filing
Feb 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $458K +31.8K +29.97% $14.40 138K Jan 7, 2022 Direct
transaction AMPH Common Stock Sale -$483K -20K -14.51% $24.15 118K Jan 7, 2022 Direct F1, F2
transaction AMPH Common Stock Sale -$293K -11.8K -10% $24.90 106K Jan 7, 2022 Direct F1
transaction AMPH Common Stock Options Exercise $230K +16K +15.09% $14.40 122K Jan 10, 2022 Direct
transaction AMPH Common Stock Sale -$406K -16K -13.11% $25.40 106K Jan 10, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Employee Stock Option (right to buy) Options Exercise $0 -31.8K -32.24% $0.00 66.8K Jan 7, 2022 Common Stock 31.8K $14.40 Direct F3
transaction AMPH Employee Stock Option (right to buy) Options Exercise $0 -16K -23.96% $0.00 50.8K Jan 10, 2022 Common Stock 16K $14.40 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.90 to $24.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price .
F3 Shares subject to the option are fully vested and immediately exercisable.